Amedisys: SEC ends Medicare-related investigation
BATON ROUGE - The Securities and Exchange Commission has wrapped up an investigation into Amedisys' participation in the federal Medicare program, and no enforcement actions will be recommended.
The Baton Rouge-based home health care and hospice services provider had announced the investigation in June 2010 and said then that it also had received a Senate Finance Committee subpoena for documents. A month earlier, the Senate committee started an investigation into the billing practices of Amedisys and some other companies.
The investigation raised questions about whether the companies increased their number of patient visits out of medical necessity or in order to deliberately trigger higher Medicare reimbursements.